Our Network of Consultants

Senior Molecular Biologist with 35+ Years of International Experience (Europe/USA)
Expertise: Gene Therapy (rAAV & Lentiviral Vectors), Synthetic Biology, Molecular Biology, Biochemistry, and Cell Biology across Mammalian, Bacterial, Yeast, and Plant Systems
 Specialised in:
- Advanced Vector Engineering: Design and validation of custom plasmids for specific in vivo and in vitro assay requirements; expression cassette engineering by selecting promoters, enhancers, regulatory elements, and seqeunce optimisation (species-tissue optimisation); tailoring of cloning and assembly methods and validation; safety and manufacturability.
- Construct Stability: Troubleshooting DNA instability challenges such as repeated sequences, ITR, GC-rich sequences, and gene toxicity.
- Regulatory Practices: Design of GMP-compliant workflows, documentation, and manufacturing alignment.

With over a decade of experience in Sales, Account Management, and Business Development across Europe, I bring a proven track record of growing revenue, structuring global sales operations, and managing complex biopharmaceutical relationships. My expertise spans both services and capital equipment (CAPEX) sales, with a consistent history of exceeding targets and closing multimillion-pound deals at executive level.

I currently operate as a Business Development and Sales Consultant for Cellevate AB and LiveDrop Bio, where I designed and implemented complete business development strategies, built CRM systems and performance dashboards, and positioned the companies among key academic and biopharma stakeholders. My recent achievements include generating leads and converting them into purchase orders through strong technical presentations and relationship-building with KOLs, CROs, and manufacturing partners.

Previously, as Global Key Account Manager at Miltenyi Biotec, I managed six global customers totaling 23 international sites, negotiated supply agreements, and developed multi-year growth strategies. I notably closed a £3.3 million CAPEX deal within two weeks and contributed €35 million toward the 2024 revenue plan. At Sartorius Stedim, I led high-value accounts across France, Benelux, and the UK, expanding revenue by more than 200% year-on-year while coordinating multi-site collaborations across R&D and manufacturing.

My career demonstrates a unique combination of scientific literacy and commercial strategy. I began in technical sales roles with Sartorius and BD, where I introduced innovative single-cell and flow cytometry technologies, managed market entry strategies, and won back blacklisted accounts through consultative negotiation. Over time, I transitioned into strategic sales leadership—defining go-to-market frameworks, establishing KPIs, and mentoring sales representatives across divisions and regions.

Fluent in both English and French, I excel in cross-cultural communication and high-level stakeholder engagement. My skill set spans consultative and strategic selling, global account mapping, contract negotiation, and profit planning. Equipped with deep knowledge of the biopharma value chain—from cell and gene therapy manufacturing to clinical and CDMO partnerships—I operate effectively within matrixed organizations and thrive in fast-evolving innovation environments.

Certified in advanced selling methodologies (Sandler, Miller Heiman, Mercuri) and completing PRINCE2 accreditation, I combine technical expertise, legal understanding, and business acumen to deliver sustainable commercial growth in the life sciences sector.

My area of study is the intersection of clinical neuroscience, translational pharmacology, and computational biomarker discovery. I am a PhD candidate investigating how glymphatic and meningeal–lymphatic pathways relate to neuroinflammation in humans. I focus on immune-cell phenotyping and cell-free markers that may index inflammatory activity and neurodegenerative trajectories. Alongside sampling development, I contribute to assay and workflow optimisation for mass-spectrometry-ready proteomics, with an emphasis on automation, quality control, and reproducibility.

My pharmacology and drug-safety foundation was built through an MRes in Biological Science and Translational Medicine. I examined dose- and time-dependent paracetamol-induced kidney injury in renal cell models, differentiating apoptotic and necrotic mechanisms and linking experimental readouts to clinically relevant nephrotoxicity questions. I completed a systematic review on cilastatin as a renoprotective strategy and critically evaluated in vitro acute kidney injury models for translational validity. I also gained ward-level exposure as a Clinical Research Associate in nephrology, aligning laboratory findings with real-world clinical pathways and multidisciplinary decision-making.

From an industry and communications perspective, I have experience in medical affairs-adjacent work, including market analysis to support launch planning in an ophthalmic pharmaceutical company and the development of compliant training materials with medical teams. I have delivered conference and hospital presentations, tailoring complex findings to both clinical and public audiences, and I have completed structured projects on European compliance frameworks, which underpins my approach to regulatorily aware medical writing.

Computationally, I build end-to-end machine-learning workflows in Python and R for noisy, high-dimensional datasets, particularly proteomics and multimodal clinical data. My toolkit spans supervised learning, unsupervised clustering, and dimensionality reduction.

Overall, my expertise is translating complex biomedical and quantitative evidence into actionable deliverables, supported by an MBA in Clinical Leadership and a strong biochemistry foundation, including earlier research on TEX12 expression in somatic and cancer models.

Over 35 years experience in life science research and the life science tools industry. 25+ years experience as a senior corporate executive in leading public and private life science tools companies, as well as board service and consulting over the past 10 years. A primary focus has been in corporate development and merger & acquisition.

Specialties: corporate development, merger and acquisition, and strategic planning in the life science tools industry

I am a freelance Quality Assurance consultant/auditor with 14 years experience in the Pharmaceutical industry and I offer QMS development/support and Lead Auditor services for Life Science and Biotech organisations. My most recent role prior to freelance work was as the Global Supplier Quality Manager for a Biotech organisation where I was responsible for management of over 100 suppliers, with oversight of a small team of auditors and conduct of audits as a Lead Auditor in support for Clinical operations, as well as development/support for the site QMS.

With over 25 years of leadership in the Life Sciences and Diagnostics market, I have built a proven track record of blending entrepreneurial vision with strategic business management expertise. Drawing from a wealth of experience across Business Development, R&D, Marketing, Sales, and Manufacturing, I have developed a deep technical foundation that drives a passion for revenue growth, market share expansion, and profit performance enhancement.

My leadership is defined by a commitment to innovation and a solution-oriented mindset, consistently helping businesses navigate complex challenges while fostering sustainable, high-impact partnerships across global markets.

Key Strengths:
• Building and scaling international distribution and sales channels
• Motivating and guiding teams to accelerate revenue growth
• Driving success in OEM and B2B sales strategies
• Leading contract negotiations, technology transactions, and licensing agreements
• Spearheading global business development across EMEA, APAC, LATAM, and Africa

By leveraging my expertise, global connections, and industry insights, companies can optimize their distribution networks, ensuring measurable results and maximizing revenue. With a focus on fine-tuning distribution strategies, together we can deliver sustainable growth across key regions.

As a strategic life sciences leader with over 14 years of experience in oncology, immuno-oncology, and cell and gene therapy, I am passionate about advancing innovative therapies that improve patient outcomes. My journey in biotech has been defined by a hands-on approach to discovery research, product development, and regulatory strategy, taking concepts from the lab bench to clinical trials.

Throughout my career, I’ve had the privilege of leading and contributing to groundbreaking projects. At TC BioPharm, I played a pivotal role in the FDA approval of an allogeneic gamma delta T cell therapy and the preclinical development of next-generation CAR-T products. My expertise in developing complex assays and driving exploratory clinical analyses has been critical in achieving key milestones, including advancing a phase 2/3 AML clinical trial.

As a consultant, I leverage my experience to guide biotech companies in refining development strategies and bridging preclinical and clinical efforts. From conducting due diligence for investments to streamlining development pathways, I provide actionable insights that reduce timelines and costs while maintaining scientific and regulatory rigour.
Collaboration is at the heart of this effort. I thrive in cross-functional teams, ensuring seamless integration across R&D, clinical, regulatory, and manufacturing functions. I also enjoy mentoring, developing talent, and fostering team innovation and resilience.

I actively contribute to the scientific community, having presented at international conferences such as the Gamma Delta T Cell Therapies Summit and the Allogeneic Cell Therapies Summit. My academic foundation, with a PhD in Medicine from the University of Glasgow, further underpins my technical expertise and commitment to translating research into impactful therapies.

Joining this network aligns with my drive to connect with like-minded professionals with a vision for transforming healthcare. I am eager to contribute my knowledge, learn from peers, and explore opportunities for collaboration that can accelerate therapeutic development and benefit patients worldwide.

Senior Life Sciences Executive and Technical Expert with 15+ years of experience driving innovation in biotechnology. Proven track record in building and scaling successful ventures, specializing in cell biology, automation, and AI-powered solutions. Currently serving as CEO of an iPSC technology company, while offering strategic consulting to emerging life science ventures.

Technical Expertise:
- Cell culture and cell line development (CLD)
- Extensive experience with cancer, CHO, HEK, cultured meat and iPSC cell lines
- Developing and validating automation and high-throughput AI-based imaging instrumentation
- Cell line optimization, immortalisation, engineering and characterization

Molecular & Synthetic Biology:
- Gene editing and genetic engineering
- Vector design and production
- Protein expression systems

Leadership Experience:
- Founded and scaled an iPSC quality control company from concept to market
- Led cross-functional teams of scientists, software engineers and engineers
- Developed and implemented automated laboratory workflows
- Successfully navigated multiple funding rounds and strategic partnerships

Industry Applications:
- Drug discovery and development
- Diagnostic platform development
- Viral vector manufacturing
- Stem cell technologies
- Vaccine development
- Recombinant protein production

Consulting Services:
- Strategic Planning
- Scientific advice
- Market entry strategy
- Technology road-mapping
- IP portfolio development
- Laboratory Operations
- Design and construction optimization
- Workflow automation

A PhD consultant in the biotechnology and life sciences industry with over 17 years of experience working internationally. Specializing in customer insights, market-driven product development and strategic marketing, with expertise in genomic medicine, gene therapy, cell therapy, nanomedicine, NGS, molecular diagnostics, oncology, and more. Held leadership positions in biotech and life sciences companies in Canada, US and UK, including Abcam, STEMCELL Technologies, Thermo Fisher Scientific, Cytiva/Danaher.

I have a a D.Phil. in Biochemistry from the University of Oxford with first author publication in Nature Immunology; an MSc from University of Toronto and a BSc (Honours) from University of British Columbia.

Consulting Services include:
Voice of Customer/Customer Insights
Market Driven Product Requirements
Value Propositions and Product Positioning
Product-Market fit
Competitor Landscape Assessments
Pricing Strategies
Go to Market Strategies